KRAS and neoplasm: Genetic ablation of STK11 in a KRAS-driven murine model of NSCLC demonstrated an accumulation of neutrophils with T-cell suppressive capacities associated with a decreased number of tumor-infiltrating lymphocytes and a reduced expression of PD-L1 in tumors [74].